Early Double Sequential Defibrillation in Out-of-hospital Cardiac Arrest

NCT06447805 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-10-01

No results posted yet for this study

Summary

Some of the patients affected by Out-of-hospital cardiac arrest (OHCA) with ventricular fibrillation (VF)/ventricular tachycardia (VT) do not respond to initial defibrillation. The survival decreases with number of defibrillations required to terminate VF/VT. In 2022, one prospective cluster randomized trial showed increased survival among (OHCA) patients in refractory VF using Double Sequential Defibrillation (DSD).

To evaluate feasibility and safety this randomized pilot trial will compare the effect of double defibrillation strategy initiated as soon as possible after the first defibrillation with continued resuscitation using standard defibrillation, in patients with Out of Hospital Cardiac arrest (OHCA). The results from this pilot trial will form the basis for design of a larger multicenter survival study.

Conditions

Interventions

DEVICE

Double Sequential Defibrillation (DSD)

The second defibrillator will be applyed with electrodes placed in the A-P position

DEVICE

Standard defibrillation

Standard defibrillation uning one defibrillator

Sponsors & Collaborators

Principal Investigators

  • Gabriel Riva, MD, PhD · Karolinska Institutet

  • Akil Awad, MD, PhD · Karolinska Institutet

  • Andreas Claesson, RN, PhD · Karolinska Institutet

  • Carl Magnusson, RN, PhD · Sahlgrenska University

  • Leif Svensson, MD, PhD · Karolinska Institutet

  • Johan Israelsson, RN, PhD · Linné University

  • Emma Blick-Nordqvist, MD · Karolinska Institutet

  • Martin Jonsson, Msc, PhD · Karolinska Institutet

  • Jacob Hollenberg, MD, PhD · Karolinska Institutet

  • Sheldon Cheskes, MD · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-05-31
Completion
2025-09-23

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06447805 on ClinicalTrials.gov